Annual Drug Patent Expirations for DESCOVY Descovy is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from two suppliers. There are six…
The post New patent expiration for Gilead Sciences drug DESCOVY appeared first o…
New patent expiration for Gilead Sciences drug DESCOVY Read Post »
Annual Drug Patent Expirations for GENVOYA Genvoya is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from two suppliers. There are thirteen…
The post New patent expiration for Gilead Sciences drug GENVOYA appeared fi…
New patent expiration for Gilead Sciences drug GENVOYA Read Post »
Annual Drug Patent Expirations for EXONDYS+51 Exondys 51 is a drug marketed by Sarepta Theraps Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Sarepta Theraps drug EXONDYS 51 appeared fir…
New patent expiration for Sarepta Theraps drug EXONDYS 51 Read Post »
Annual Drug Patent Expirations for VYONDYS+53 Vyondys 53 is a drug marketed by Sarepta Theraps Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Sarepta Theraps drug VYONDYS 53 appeared fir…
New patent expiration for Sarepta Theraps drug VYONDYS 53 Read Post »
Annual Drug Patent Expirations for ATRIPLA Atripla is a drug marketed by Gilead Sciences and is included in one NDA. It is available from two suppliers. There are nine patents…
The post New patent expiration for Gilead Sciences drug ATRIPLA appeared fi…
New patent expiration for Gilead Sciences drug ATRIPLA Read Post »
Annual Drug Patent Expirations for EMTRIVA Emtriva is a drug marketed by Gilead and is included in two NDAs. It is available from two suppliers. There are two patents protecting…
The post New patent expiration for Gilead drug EMTRIVA appeared first on …
Annual Drug Patent Expirations for AMONDYS+45 Amondys 45 is a drug marketed by Sarepta Theraps Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Sarepta Theraps drug AMONDYS 45 appeared fir…
New patent expiration for Sarepta Theraps drug AMONDYS 45 Read Post »
Annual Drug Patent Expirations for VIBATIV Vibativ is a drug marketed by Cumberland Pharms and is included in one NDA. It is available from one supplier. There are eleven patents…
The post New patent expiration for Cumberland Pharms drug VIBATIV appear…
New patent expiration for Cumberland Pharms drug VIBATIV Read Post »
VIBATIV (telavancin hydrochloride) Cumberland pharms Patent: 7,544,364 Expiration: May 1, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The …
Drug Patent Expirations for the Week of April 25, 2021 Read Post »
Annual Drug Patent Expirations for ZYDELIG Zydelig is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are thirteen…
The post New patent expiration for Gilead Sciences drug ZYDELIG appeared fir…
New patent expiration for Gilead Sciences drug ZYDELIG Read Post »